Holzer P, Holzer-Petsche U, Leander S
Br J Pharmacol. 1986 Nov;89(3):453-9. doi: 10.1111/j.1476-5381.1986.tb11144.x.
The effect of a substance P antagonist, [D-Pro2, D-Trp7,9]-substance P (SPA), on gastric emptying and gastrointestinal transit in the rat was studied in order to elucidate a possible physiological role of endogenous substance P and other tachykinins in gastrointestinal motility. SPA was given by intraperitoneal injection concurrently with the intragastric administration of a test meal containing charcoal and 51Cr. Examination 15 min after the test meal showed that SPA (0.13-1.3 mumol kg-1) inhibited gastric emptying and gastrointestinal transit in a dose-dependent manner. The inhibitory effect of SPA on gastric emptying and gastrointestinal transit remained unchanged after pretreatment of rats with mepyramine (8.7 mumol kg-1) plus cimetidine (19.8 mumol kg-1) or with guanethidine (67 mumol kg-1). Since a full examination of SPA as a specific tachykinin antagonist was not possible in vivo, SPA was also tested on circular muscle strips from the rat gastric corpus in vitro. Submaximal contractions in response to bombesin or bethanechol were not reduced by SPA (50 microM), whereas those in response to substance P were inhibited. The results suggest that SPA inhibits gastric emptying and gastrointestinal transit by interfering with the action of tachykinins released from enteric nerves and that endogenous tachykinins are involved in the regulation of gastrointestinal motility.
为阐明内源性P物质及其他速激肽在胃肠运动中可能的生理作用,研究了P物质拮抗剂[D-脯氨酸2,D-色氨酸7,9]-P物质(SPA)对大鼠胃排空和胃肠传输的影响。腹腔注射SPA的同时经胃内给予含木炭和51Cr的试验餐。试验餐后15分钟的检查显示,SPA(0.13 - 1.3 μmol kg-1)以剂量依赖性方式抑制胃排空和胃肠传输。在用美吡拉敏(8.7 μmol kg-1)加西咪替丁(19.8 μmol kg-1)或胍乙啶(67 μmol kg-1)预处理大鼠后,SPA对胃排空和胃肠传输的抑制作用保持不变。由于在体内无法对SPA作为特异性速激肽拮抗剂进行全面检查,因此还在体外对大鼠胃体的环形肌条进行了SPA测试。SPA(50 μM)并未降低对蛙皮素或氨甲酰甲胆碱的亚最大收缩反应,但抑制了对P物质的收缩反应。结果表明,SPA通过干扰从肠神经释放的速激肽的作用来抑制胃排空和胃肠传输,且内源性速激肽参与胃肠运动的调节。